259 related articles for article (PubMed ID: 11941942)
1. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
Nakama H; Fukazawa K
Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
[TBL] [Abstract][Full Text] [Related]
2. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding.
Nakama H; Kayano T; Katsuura T; Kamigaito T; Shimada S; Nishikawa N; Yoshii S; Kamijo N
Hepatogastroenterology; 1999; 46(27):1730-2. PubMed ID: 10430332
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps.
Nakama H; Fattah A; Zhang B; Uehara Y; Wang C
Hepatogastroenterology; 2000; 47(32):386-9. PubMed ID: 10791196
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of immunochemical fecal occult blood test for small colorectal neoplasms.
Abdul Fattah AS; Nakama H; Zhang B; Uehara Y; Kamijo N; Fujimori K
Eur J Med Res; 1997 May; 2(5):227-30. PubMed ID: 9153349
[TBL] [Abstract][Full Text] [Related]
5. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test.
Abdul Fattah AS; Nakama H; Kamijo N
Eur J Med Res; 1997 Aug; 2(8):361-4. PubMed ID: 9262491
[TBL] [Abstract][Full Text] [Related]
7. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopic screening of asymptomatic first-degree relatives of colorectal cancer patients.
Croitoru L; Trifan A; Maxim MR; Girleanu I; Hulub A; Dimache M; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):683-6. PubMed ID: 21235115
[TBL] [Abstract][Full Text] [Related]
10. Risk factors in asymptomatic subjects screened for colorectal cancer.
Griffiths EK; Shapira DV
Cancer Detect Prev; 1990; 14(6):647-50. PubMed ID: 2257563
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening.
Zhang B; Fattah A; Nakama H
Hepatogastroenterology; 2000; 47(32):414-8. PubMed ID: 10791202
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases.
Nishida H; Urano S
Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345
[TBL] [Abstract][Full Text] [Related]
13. [Colonoscopic screening of asymptomatic individuals with a family history of colorectal cancer].
Maxim M; Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):993-7. PubMed ID: 21500448
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
Nakama H; Kamijo N
Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
[TBL] [Abstract][Full Text] [Related]
15. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
[TBL] [Abstract][Full Text] [Related]
16. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
[TBL] [Abstract][Full Text] [Related]
17. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
18. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study.
Lage P; Cravo M; Sousa R; Chaves P; Salazar M; Fonseca R; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo P; Nobre-Leitão C
Am J Gastroenterol; 2004 Sep; 99(9):1779-84. PubMed ID: 15330918
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
Yamamoto M; Nakama H
Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
[TBL] [Abstract][Full Text] [Related]
20. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
